ENTRY       D10839            Mixture   Drug
NAME        Norelgestromin and ethinyl estradiol;
            Evra (TN);
            Xulane (TN);
            Zafemy (TN)
PRODUCT
  GENERIC   NORELGESTROMIN AND ETHINLY ESTRADIOL (Amneal Pharmaceuticals NY LLC)
            XULANE (Mylan Pharmaceuticals)
            ZAFEMY (Amneal Pharmaceuticals LLC)
            ZAFEMY (AvKARE)
COMPONENT   Norelgestromin [DR:D05205], Ethinyl estradiol [DR:D00554]
REMARK      ATC code: G03AA13
            Product: D10839<US>
EFFICACY    Contraceptive
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
               G03A HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
                G03AA Progestogens and estrogens, fixed combinations
                 G03AA13 Norelgestromin and ethinylestradiol
                  D10839  Norelgestromin and ethinyl estradiol &lt;US&gt;
            USP drug classification [BR:br08302]
             Contraceptives
              Contraceptives, Other
               Norelgestromin/ Ethinyl Estradiol
                D10839  Norelgestromin and ethinyl estradiol
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10839
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10839
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10839
DBLINKS     PubChem: 319902639
///
